Form 4: Privia Health Director Matthew Morris Receives Equity Grant Under Incentive Plan

Privia Health Group, Inc. Director Matthew Shawn Morris was granted 8,396 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Summary

• On May 21, 2025, Matthew Shawn Morris, a Director of Privia Health Group, Inc. (PRVA), received a grant of 8,396 restricted stock units (RSUs).
• These RSUs were granted under the Issuer's 2021 Omnibus Incentive Plan at a price of $0 per unit.
• The restricted stock units are set to vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders or (ii) the first anniversary of the grant date.
• Following this transaction, Mr. Morris beneficially owns a total of 68,188 shares of Common Stock directly.
• Additionally, Mr. Morris indirectly beneficially owns 12,487 shares through Emerald Family, LLC and 11,998 shares through a Trust.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a positive sign of aligning management interests with shareholder value, representing a standard component of executive compensation. It does not indicate any negative operational or financial issues.

Positives

• The grant of restricted stock units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• Equity grants are a standard component of director compensation, indicating a routine and expected compensation practice.

Future Outlook

The restricted stock units granted to Director Matthew Shawn Morris are scheduled to vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date, indicating a future alignment of interests.

Industry Context

Equity grants, such as restricted stock units, are a common form of compensation for directors and executives across various industries, including healthcare, to incentivize long-term performance and align their interests with those of shareholders.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with shareholder value, potentially encouraging decisions that benefit long-term stock performance.

Next Steps

• Vesting of the 8,396 restricted stock units on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date.

Key Dates

Recommendation

Keywords

Privia Health Group, PRVA, Form 4, Insider Transaction, Restricted Stock Units, Equity Grant, Director Compensation, Beneficial Ownership